Johns Hopkins
Previse Ramps up Commercialization of Barrett's Esophagus Test, Developing Esophageal Cancer Assay
Premium
The company currently offers a risk stratification test for Barrett's esophagus and is developing an early detection test for esophageal cancer.
A study by researchers at Johns Hopkins and the Canadian Cancer Trials Group demonstrated that early molecular therapy response correlated well with radiographic findings.
BostonGene, Johns Hopkins University Partner for Multiple Cancer Clinical Research Projects
The partners plan to analyze patients' tumors, immune systems, and tumor microenvironments to predict treatment response and identify targetable molecular alterations.
Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection
Premium
Investigators are assessing performance in a prospective cohort with hopes that the method can be used to complement currently used imaging surveillance.
The method, called GEMINI, improved detection of both overall cancer and the earliest-stage cancers when added to the firm's existing platform.